Costs varied across 5 European countries, driven primarily by repeated primary care visits and parental work absences.

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic ...

Widespread use of maternal RSV vaccination and nirsevimab during the 2024–2025 U.S. RSV season led to a significant reduction ...

RSV-NET data showed that RSV hospitalization rates among infants aged 0 to 7 months were an estimated 43% (95% confidence ...

As winter nears and the cold and flu season sets in, the highly infectious respiratory virus RSV has again begun its ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

On the heels of a fall and winter that saw hundreds of Alberta babies and toddlers hospitalized and two young children die ...

As the chill of winter approaches, most of us are well-versed in the annual warnings about the flu and, more recently, ...

SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a new rapid diagnostic testing ...

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

Kellee was diagnosed with Respiratory Syncytial Virus (RSV), a virus many assume is only serious for young children. For ...